Koizumi T, Yamane Y
Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Chem Biol Interact. 1988;67(3-4):185-97. doi: 10.1016/0009-2797(88)90057-9.
Pretreatment with Na2MoO4 protected rats from HgCl2-induced decreases in the renal concentration of amino acids, RNA, DNA, ATP and dry matter. It also reduced the mercury-induced increases in renal water, Ca and serum creatinine. Ma2MoO4 considerably elevated the RNA/DNA ratio in the renal cortex after treatment with HgCl2. In addition, subcellular distribution of mercury was markedly altered by pretreatment with Na2MoO4, specifically Na2MoO4 pretreatment decreased the mercury content in the particulate fractions such as the nuclei and mitochondria while increasing the mercury content of the cytosol. Sephadex G-75 gel filtration showed that the increase in mercury content in the cytosol of Na2MoO4-pretreated rats is due to an increase in the metal content of a metallothionein-like fraction. These results suggest that Na2MoO4-pretreatment protects against HgCl2 renal toxicity by stimulating mercury-mediated metallothionein induction in the renal cortex and renal regenerative processes.
用钼酸钠预处理可保护大鼠免受氯化汞诱导的肾脏中氨基酸、RNA、DNA、ATP和干物质浓度降低的影响。它还降低了汞诱导的肾脏水分、钙和血清肌酐的增加。在用氯化汞处理后,钼酸钠显著提高了肾皮质中的RNA/DNA比值。此外,钼酸钠预处理显著改变了汞的亚细胞分布,具体而言,钼酸钠预处理降低了细胞核和线粒体等颗粒部分中的汞含量,同时增加了细胞质中的汞含量。葡聚糖凝胶G-75凝胶过滤显示,钼酸钠预处理大鼠细胞质中汞含量的增加是由于类金属硫蛋白部分的金属含量增加所致。这些结果表明,钼酸钠预处理通过刺激肾皮质中汞介导的金属硫蛋白诱导和肾脏再生过程来预防氯化汞的肾毒性。